Company Number: SC697350

Analysis Date: 2025-07-29 13:14 UTC

1. Credit Opinion: APPROVE
   Dr A Maan Ltd demonstrates a strong and improving financial position for a micro-entity. The company has shown significant growth in net current assets and shareholders' funds over the last three years, indicating good operational management and financial control. There is no indication of overdue filings or financial distress. The company is active in hospital activities, a sector typically associated with steady demand. The directors appear stable with no adverse records. Given these factors, the company is assessed as capable of servicing credit facilities, subject to normal lending terms and limits appropriate for a micro-sized business.

2. Financial Strength:
   The balance sheet shows a solid and improving equity base—shareholders' funds increased from £56,876 in 2021 to £206,010 in 2024. Fixed assets are minimal (£3,078), indicating limited capital investment, which is typical for a service-oriented business. The significant increase in current assets (mainly cash or receivables) alongside decreasing current liabilities from £60,227 in 2023 to £40,456 in 2024 suggests strengthened liquidity and reduced short-term obligations. The company has a strong net current asset position (£202,932), providing a comfortable liquidity buffer.

3. Cash Flow Assessment:
   While cash flow statements are not provided, the substantial increase in current assets and net current assets implies healthy working capital management and likely positive operating cash flows. The absence of employees reduces fixed overhead costs and cash burn risk. Management appears to maintain conservative liability levels with current liabilities well covered by current assets. Overall liquidity is strong, reducing the risk of payment delays or default on short-term obligations.

4. Monitoring Points:

• Maintain vigilance on cash conversion cycles and debtor collections to sustain liquidity.
• Watch for any increase in current liabilities that could pressure working capital.
• Monitor sector-specific risks in hospital activities, including regulatory changes or funding fluctuations.
• Track any changes in director appointments or adverse notices that might affect governance or creditworthiness.